MARI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 8.485
NA - Nord America 3.848
EU - Europa 1.506
SA - Sud America 1.459
AF - Africa 278
Continente sconosciuto - Info sul continente non disponibili 122
OC - Oceania 8
Totale 15.706
Nazione #
SG - Singapore 4.354
US - Stati Uniti d'America 3.478
CN - Cina 1.099
BR - Brasile 1.012
HK - Hong Kong 665
VN - Vietnam 557
IT - Italia 516
BD - Bangladesh 336
FR - Francia 312
KR - Corea 201
IN - India 178
DE - Germania 176
TR - Turchia 161
MX - Messico 127
IQ - Iraq 120
RU - Federazione Russa 108
JP - Giappone 101
AR - Argentina 96
VE - Venezuela 95
SA - Arabia Saudita 90
PH - Filippine 87
CA - Canada 85
CO - Colombia 82
ID - Indonesia 81
UA - Ucraina 73
GB - Regno Unito 72
MY - Malesia 72
UZ - Uzbekistan 72
EC - Ecuador 67
MA - Marocco 64
KE - Kenya 52
NL - Olanda 47
ZA - Sudafrica 47
FI - Finlandia 45
IR - Iran 45
JM - Giamaica 43
UY - Uruguay 36
PY - Paraguay 35
JO - Giordania 32
AZ - Azerbaigian 31
HN - Honduras 30
EG - Egitto 29
KZ - Kazakistan 29
IL - Israele 28
CR - Costa Rica 26
MM - Myanmar 24
NP - Nepal 23
PK - Pakistan 21
ES - Italia 20
PL - Polonia 20
AL - Albania 19
TN - Tunisia 18
DZ - Algeria 17
CL - Cile 15
AT - Austria 14
GE - Georgia 13
BG - Bulgaria 12
BO - Bolivia 12
PA - Panama 12
TH - Thailandia 11
TT - Trinidad e Tobago 11
CI - Costa d'Avorio 10
AM - Armenia 9
KG - Kirghizistan 8
SN - Senegal 8
BH - Bahrain 7
GT - Guatemala 7
IE - Irlanda 7
AU - Australia 6
PE - Perù 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
CG - Congo 5
DO - Repubblica Dominicana 5
NO - Norvegia 5
PR - Porto Rico 5
PT - Portogallo 5
SE - Svezia 5
SV - El Salvador 5
TW - Taiwan 5
BY - Bielorussia 4
GA - Gabon 4
GR - Grecia 4
HU - Ungheria 4
OM - Oman 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
EE - Estonia 3
LT - Lituania 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
SC - Seychelles 3
ZM - Zambia 3
BB - Barbados 2
BF - Burkina Faso 2
BJ - Benin 2
Totale 15.539
Città #
Singapore 3.384
Santa Clara 770
Hong Kong 658
Hefei 482
San Jose 404
Ashburn 309
Lauterbourg 257
Seoul 196
Ho Chi Minh City 191
Beijing 180
Dallas 167
Hanoi 137
Frankfurt am Main 125
New York 100
Los Angeles 94
Tokyo 73
São Paulo 71
Rome 65
Tashkent 65
Milan 63
Buffalo 62
Istanbul 52
Nairobi 48
Jeddah 41
Kuala Lumpur 36
Baghdad 35
Amman 31
Brooklyn 30
Helsinki 29
Montevideo 29
Baku 28
Kingston 28
Caracas 26
Chicago 25
North Bergen 25
Rio de Janeiro 25
Brasília 24
Quito 24
Riyadh 24
Biên Hòa 23
Minamishinagawa 23
Bengaluru 22
Council Bluffs 22
Florence 22
Belo Horizonte 20
Erbil 20
Guangzhou 20
Guayaquil 20
Orem 20
Phoenix 20
San José 20
Atlanta 19
Haiphong 19
Asunción 18
Da Nang 18
Jakarta 18
Newark 18
Toronto 18
Bogotá 17
Houston 17
Johannesburg 17
Curitiba 16
Maracaibo 16
Naples 16
New Delhi 16
Nuremberg 16
Quezon City 16
Casablanca 15
Dhaka 15
Duhok 15
El Progreso 15
Lappeenranta 15
Philadelphia 15
Tirana 15
Dammam 14
Jacksonville 14
London 14
Boardman 13
Chennai 13
Guarulhos 13
Miami 13
Montreal 13
Tbilisi 13
Medellín 12
Milwaukee 12
Padova 12
Salvador 12
Campinas 11
Charlotte 11
Genoa 11
Mexico City 11
Moscow 11
Queens 11
Sorocaba 11
Washington 11
Yangon 11
Abidjan 10
Bari 10
Izmir 10
Manila 10
Totale 9.352
Nome #
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models 4.810
Effects of low-carbohydrate versus mediterranean diets on weight loss, glucose metabolism, insulin kinetics and ?-cell function in morbidly obese individuals 120
The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study 115
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials 111
Prospective associations of dietary carbohydrate, fat, and protein intake with ?-cell function in the CODAM study 103
A reference map of potential determinants for the human serum metabolome 95
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study 88
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance 88
Depressive symptoms, insulin sensitivity and insulin secretion in the RISC cohort study 86
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions 84
Long-term effects of bariatric surgery on meal disposal and ss-cell function in diabetic and nondiabetic patients 84
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 84
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study 81
Effects of Obesity and Exercise on Hepatic and Pancreatic Lipid Content and Glucose Metabolism: PET Studies in Twins Discordant for BMI. 81
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial 81
Defective amplifying pathway of ?-cell secretory response to glucose in type 2 diabetes: Integrated modeling of in vitro and in vivo evidence 79
Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x) 78
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study 75
Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals 74
Mechanism of progression to diabtes in relatives of type 1 Diabetic patients 73
Inhibition of sweet chemosensory receptors alters insulin responses during glucose ingestion in healthy adults: A randomized crossover interventional study 73
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes 72
Does DPP-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? - a randomized controlled trial 72
Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance 71
SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes 69
Methods of assessment of insulin sensitivity and beta-cell function 68
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration 66
Brain substrate metabolism and ß-cell function in humans: A positron emission tomography study 65
Association of artificially sweetened and sugar-sweetened soft drinks with ?-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study 65
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits 64
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity 63
Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis 62
Associations between sleep duration and sleep debt with insulin sensitivity and insulin secretion in the EGIR-RISC Study 62
New insights on the interactions between insulin clearance and the main glucose homeostasis mechanisms 62
Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes 62
Influence of Hyperinsulinemia and Insulin Resistance on In Vivo beta-Cell Function Their Role in Human beta-Cell Dysfunction 61
Exenatide improves beta-cell function up to 3 years of treatment in patients with type 2 diabetes: A randomised controlled trial 61
Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development 61
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes 61
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects 61
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients 59
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial 58
The influence of metformin treatment on the circulating proteome 58
Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response 57
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea 57
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose Sensitivity 56
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux 55
Beta-cell function in obesity: effects of weight loss 55
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 55
Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study 55
Dapagliflozin lowers plasma glucose concentration and improves beta-cell function 54
Characterization of the Influence of Vildagliptin on Model-Assessed b-Cell Function in Patients with Type 2 Diabetes and Mild Hyperglycemia 53
The effect of a vegetarian versus conventional hypocaloric diet on serum concentrations of persistent organic pollutants in patients with type 2 diabetes 52
Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men 52
Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study 51
Model description language (MDL): A standard for modeling and simulation 51
Obesity and carotid artery remodeling 51
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 51
Potentiation of the early-phase insulin response by a prior meal contributes to the second-meal phenomenon in type 2 diabetes 50
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models 50
Effect of acute hyperglycemia on insulin secretion in humans 49
Influence of hepatic and peripheral insulin resistance on glucose tolerance in non diabetic subjects: the RISC study. 48
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms 48
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes 48
Post-dinner resistance exercise improves postprandial risk factors more effectively than pre-dinner resistance exercise in patients with type 2 diabetes 48
Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients 47
Disruption of fasting and post-load glucose homeostasis are largely independent and sustained by distinct and early major beta-cell function defects: a cross-sectional and longitudinal analysis of the Relationship between Insulin Sensitivity and Cardiovascular risk (RISC) study cohort 45
Effect of single-dose DPP-4 inhibitor sitagliptin on beta-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects 45
Thiazolidinediones improve beta-cell function in type 2 diabetic patients 45
Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test 45
Improvements in beta cell function parameteres during 52-week treatment with vildagliptin in patients mild hyperglycaemia 44
Effect of exenatide on postprandial glucose fluxes, lipolysis function in non-diabetic, morbidly obese patients 44
Associations of dietary glucose, fructose, and sucrose with ?-cell function, insulin sensitivity, and type 2 diabetes in the maastricht study 44
Effect of dapagliflozin with and without acipimox on insulin sensitivity and insulin secretion in T2DM males 43
The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function 43
Relationships between glucose clearance during an ogtt and a euglycemic clamp 42
Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects 42
Characterization of GLP-1 Effects on beta-Cell Function After Meal Ingestion in Humans 42
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function 41
Valutazione dell efficacia di un farmaco antidiabetico prodotto da un azienda USA 41
The heritability of beta cell function parameters in a mixed meal test design 41
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients 41
Glucose sensitivity, insulin sensitivity and their longitudinal changes are strong independent determinants of type 2 diabetes progression: an IMI DIRECT study 41
Beta-cells in youth with impaired glucose tolerance or early type 2 diabetes secrete more insulin and are more responsive than in adults 41
m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction 40
Imeglimin increases glucose-dependent insulin secretion and improves beta-cell function in patients with type 2 diabetes 40
Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women 40
The effect of alogliptin and pioglitazone combination therapy on various aspects of ?-cell function in patients with recent-onset type 2 diabetes 40
Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones 40
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects The RISC Study 40
Applicazioni di modelli matematici per la fisiologia 40
A mathematical modelling of the beta cell explaining in vitro and in vivo findings with consistent mechanisms 39
Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant 39
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 39
Nonalcoholic Fatty Liver Is Not Associated with the Relationship between Insulin Secretion and Insulin Sensitivity in Obese Children: Matched Case-Control Study 39
Applicazione web per il calcolo di parametri farmacocinetici 39
Valutazione della sensibilità all insulina e della funzione betacellulare con modelli matematici 38
Assessing insulin secretion by modeling in multiple meal tests: role of potentiation 38
Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes 38
Valutazione della sensibilità all insulina e della funzione beta cellulare con modelli matematici 38
Totale 10.556
Categoria #
all - tutte 46.055
article - articoli 42.456
book - libri 238
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 5 0 9 4
2024/20255.163 30 28 245 154 641 136 100 86 154 620 1.523 1.446
2025/20269.104 1.039 1.342 1.494 1.274 952 220 932 341 322 327 407 454
2026/20271.421 311 291 819 0 0 0 0 0 0 0 0 0
Totale 15.706